FGF2 and ischemia: Very recently, the PJI has been reported to be successfully applied to gene therapy by intramuscular delivery of plasmid DNA of basic fibroblast growth factor (bFGF) into muscle tissues of the ischemia-induced muscle injury model mice [45].